Kidney TransplantationImmunosuppressive AgentsGraft RejectionOrgan TransplantationTacrolimusCyclosporineHeart TransplantationTransplantationLung TransplantationTransplantsLiver TransplantationGraft SurvivalMycophenolic AcidTransplantation, HomologousTissue and Organ ProcurementTissue DonorsPostoperative ComplicationsCytomegalovirus InfectionsImmunosuppressionTime FactorsBone Marrow TransplantationRetrospective StudiesImmunocompromised HostBK VirusTreatment OutcomePolyomavirus InfectionsTransplantation ImmunologyKidney Failure, ChronicCyclosporinsDrug MonitoringHeart-Lung TransplantationBronchiolitis ObliteransKidneyCytomegalovirusLiving DonorsLiver FailureSirolimusWaiting ListsTablets, Enteric-CoatedMultiple Organ FailureCalcineurinRisk FactorsBiopsyLymphoproliferative DisordersPancreas TransplantationFollow-Up StudiesGingival OvergrowthHematopoietic Stem Cell TransplantationAntilymphocyte SerumHistocompatibility TestingProspective StudiesKidney DiseasesCreatininePostoperative PeriodGanciclovirOrgan SizeOrgan of CortiOrgan SpecificityAntiviral AgentsOpportunistic InfectionsIncidenceIsoantibodiesCadaverDrug Therapy, CombinationGraft vs Host DiseaseEnd Stage Liver DiseaseMycosesAzathioprineMonitoring, ImmunologicRecurrenceRenal DialysisTransplantation ToleranceKidney Function TestsBiological MarkersAcute DiseaseLiver DiseasesGlomerular Filtration RateArea Under CurvePolymerase Chain ReactionSurvival AnalysisRenal InsufficiencyLiverPostoperative CarePrednisoneAspergillosisFetal Tissue TransplantationAntifungal AgentsPrognosisGingival HyperplasiaIMP DehydrogenaseSurvival RateHLA AntigensTransplantation, AutologousHerpesvirus 6, HumanCohort StudiesBrain DeathPrimary Graft DysfunctionTransplantation ConditioningCytochrome P-450 CYP3ARisk Assessment